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ISince the 19th century, searches for the pathogen-esis of interstitial cystitis/bladder pain syndrome(IC/BPS) have concentrated on the bladder. How-
ver, recent work has shown that patients with IC/BPS
re more likely than controls to have syndromes with
ymptoms beyond the bladder and even the pelvis. These
ndings suggest that research into IC/BPS etiology
hould not focus only on the bladder.
The sequence of investigation of nonbladder syn-
romes (NBSs) and IC/BPS has been similar to that for
ost medical research: case series generating hypotheses
hat are then tested in controlled studies. For instance, an
ften-cited survey of patients with IC/BPS showed an
pparently high prevalence of fibromyalgia (FM), chronic
atigue syndrome (CFS), irritable bowel syndrome (IBS),
llergy, asthma, vulvodynia, and several other diseases
nd syndromes.1 Recent controlled studies have con-
firmed most of these findings. We believe that these
studies have integrated important facts into the knowl-
edge of IC/BPS. The present report presents these facts,
formulates the hypotheses they generate, and suggests
pathways to test these hypotheses.
THE FACTS
Many NBSs are Associated With IC/BPS
Clauw et al2 were among the first to show that patients
with IC/BPS were more likely than controls to have an
NBS (ie, FM). Moreover, during the past 5 years, inves-
tigators compared patients with IC/BPS with controls for
multiple NBSs. Wu et al3 identified 749 patients with
C/BPS diagnosed using the International Classification
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Open access under the Elsevier OA license.f Diseases (ICD). They compared them with 1498 ran-
omly selected and matched controls. Significantly more
C/BPS patients had FM, IBS, chronic pelvic pain
CPP), endometriosis, depression, anxiety, and vulvo-
ynia.
Clemens et al4 identified 239 women with ICD-coded
C/BPS and compared them with 717 matched controls.
he incidence of myalgias, gastrointestinal symptoms,
ynecologic pain, headache, back disorders, depression,
nd anxiety was significantly greater in IC/BPS patients
han in controls.
In a study of the risk factors for IC/BPS discussed later
n the present report, Warren et al5 demonstrated that
ignificantly more patients with IC/BPS than matched
ontrols had these 11 antecedent syndromes: FM, CFS,
BS, sicca syndrome, CPP, migraine, allergies, asthma,
epression, panic disorder, and vulvodynia.
In several urology practices on 3 continents, Nickel et
l6 found a significantly greater prevalence of self-re-
orted FM, CFS, IBS, migraine and tension headaches,
ulvodynia, temporomandibular disorder, and low back
ain in 207 women with IC/BPS than in 117 controls, as
ell as significantly more IC/BPS cases with depression
nd anxiety.7
A recent review confirmed that FM, CFS, and IBS are
associated with IC/BPS.8
Baranowski et al9 suggested a 3-group framework to
assess IC/BPS and NBSs. One group would have only
bladder symptoms. The second would have symptoms
perceived in other pelvic organs, thus possibly represent-
ing central sensitization (ie, pain generated from 1 pelvic
organ that is perceived in other pelvic sites because the
second order neurons in the spinal cord also receive
signals from those sites).10 The third group would be
atients with IC/BPS with systemic syndromes, a group
equiring a mechanism beyond the lower spinal cord to
xplain these anatomically remote symptoms.
Two cited studies distributed IC/BPS cases using the
-group framework. Warren et al5 noted that 7% of
atients had only IC/BPS (ie, with none of the associated
yndromes). Only 2% had pelvic syndromes (ie, CPP,
BS, vuvodynia), but no systemic syndromes. The re-
ainder, 91%, were in the third, systemic, category with
0090-4295/11 727
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tsyndromes such as FM, CFS, or migraine.5 Nickel et al6
used 3 NBSs to assign patients with IC/BPS to pheno-
types that roughly corresponded to the groups denoted by
Baranowski et al9: IC/BPS only, regional pain (IC/BPS
with only IBS), and systemic pain (IC/BPS with IBS plus
FM and/or CFS). Of the 207 patients with IC/BPS, 176
could be grouped as follows: 56% with IC/BPS only, 27%
with regional pain, and 16% with systemic pain. These 2
studies suggest that the more NBSs used to define the
groups, the fewer patients who have only IC/BPS or pelvic
symptoms.
NBSs Associated With Each Other
By factor analysis, most of the NBSs appear in 4 clusters.5
Thus, IC/BPS patients with FM would be more likely to
have CFS, IBS, and sicca syndrome than if they did not
have FM (cluster 1). Similarly, CPP and migraine ap-
peared together (cluster 2), as did depression and anxiety
(cluster 3) and allergy and asthma (cluster 4).5 Outside
the context of IC/BPS, others have shown similar clus-
ters.11,12
These NBSs have many similarities, other than comor-
bidity: symptom-based diagnosis, prominent pain in
most, overrepresentation in women, normal local histo-
logic findings, nondiagnostic laboratory tests, chronicity,
and an unknown etiology. Because of these similarities,
FM, CFS, temporomandibular disorder, and IBS are com-
monly discussed together as functional somatic syn-
dromes (FSSs). CPP and migraine are sometimes in-
cluded as FSSs, and depression and anxiety are often
associated with FSSs.13-17 Interestingly, characteristics of
C/BPS are those of the FSSs, suggesting that IC/BPS
tself might be an FSS.
BSs Precede or Follow IC/BPS
n 2001, Aaron et al18 noted the importance of temporal
relationships among unexplained clinical conditions for
understanding their pathogeneses.
NBSs Precede IC/PBS. Two studies demonstrated that
NBSs precede IC/BPS. Wu et al19 examined the future
robability of an IC/BPS diagnosis in patients with FM,
BS, CPP, or vulvodynia. Groups ranging from 23 000 to
6 000 patients had an ICD diagnosis for each of these
yndromes. Those with each syndrome had a significantly
reater risk of an ICD diagnosis of IC/BPS during the
ext 3 years than those without.
Seeking the risk factors for IC/BPS, Warren et al5
compared 312 patients with incident IC/BPS with
matched controls on antecedent NBSs. They studied
female patients with IC/BPS onset (index) date 12
onths earlier. Matched controls were recruited by
andom digit telephone dialing. Eleven syndromes
ere reported to have preceded the index date by
ignificantly more patients than controls. In 71%-95%
f the patients, these syndromes preceded IC/BPS by
12 months.5 p
728NBSs Follow IC/PBS. However, NBSs also follow the
onset of IC/BPS. Alagiri et al1 reported, without data,
that patients with prevalent IC/BPS recalled that mi-
graine tended to precede IC/BPS and FM and CFS
tended to follow it. Clemens et al20 recently reported in
abstract form a population-based survey that asked 534
women with IC/BPS about NBS onset dates. The
proportion of patients reporting that a given NBS
preceded IC/BPS was 69% for migraine, 59% for IBS,
46% for CFS, 44% for depression, 39% for panic, and
36% for FM.
Nickel et al6 presented data consistent with NBSs
ccurring after IC/BPS. The pertinent observation was
hat the mean duration of IC/BPS occurred in the fol-
owing pattern: IC/BPS only was shorter than IC/BPS
ith IBS which was shorter than IC/BPS with IBS, plus
M and/or CFS.
Controls have not been compared; however, integra-
ion of 2 studies suggests that the incidence of some NBSs
fter IC/BPS is likely greater in patients with IC/BPS
han in controls. Warren et al5 demonstrated that the
incidence of NBSs before IC/BPS was significantly
greater in those with IC/BPS than in controls. The
survey by Clemens et al20 reported that in patients with
prevalent IC/PBS, one half or more of several NBSs
appeared after IC/BPS onset. Linking these data suggests
that after IC/BPS onset, patients have a greater incidence
of NBSs than do controls.
Multiple NBSs Increase Risk of IC/BPS
Two studies have reported that multiple NBSs predict
IC/BPS. Warren et al demonstrated that the number of
antecedent NBSs was associated with the risk of IC/BPS21
(Table 1). The types of NBSs were skewed, allergy being
over-represented in those with few NBSs, and FM, CFS,
and IBS in those with many NBSs.21 Wu et al19 did not
Table 1. Prevalence and odds ratios for IC/BPS stratified
by number of antecedent nonbladder syndromes in pa-
tients with recent onset IC/BPS and controls
NBSs*
(n)
Patients
(n  312)
Controls
(n  313)
Odds Ratio
(95% CI)
0 22 (7.1) 55 (17.6) Reference
1 48 (15.4) 116 (37.1) 1.0 (0.6-1.9)
2 70 (22.4) 68 (21.7) 2.6 (1.4-4.7)
3 61 (19.6) 30 (9.6) 5.1 (2.6-9.8)
4 41 (13.1) 21 (6.7) 4.9 (2.4-10.0)
5 32 (10.3) 15 (4.8) 5.3 (2.4-11.7)
6 38 (12.2) 8 (2.6) 11.9 (4.8-29.5)
IC/PBS, interstitial cystitis/bladder pain syndrome; NBSs, non-
bladder syndromes; CI, confidence interval.
Data presented as number of patients, with percentages in
parentheses, unless otherwise noted.
Data from Warren et al.21
* Eleven antecedent NBSs: chronic fatigue syndrome, fibromyal-
gia, irritable bowel syndrome, sicca syndrome, chronic pelvic
pain, migraine, depression, panic disorder, allergy, asthma, and
vulvodynia.resent data but stated that “multiple diagnoses of (FM,
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nIBS, CPP, and/or vulvodynia) . . . are significant predic-
tors of future IC diagnosis.”19
Additionally, 2 investigations report that the preva-
lence of IC/BPS is greater in those with multiple NBSs
than those with fewer. Nickel et al6 (for the present
eport) calculated that the odds of IC/PBS increased with
ncreasing numbers of NBSs (Table 2). A Swedish study
f 28 000 twins used latent class analysis to group
ubjects according to 9 symptoms12; 5 classes were iden-
ified. The largest had none of the symptoms; 1 class each
as characterized by headache, bowel symptoms, and
idespread pain. The fifth class had many symptoms; the
reatest prevalence of CFS, FM, IBS, depression, and
nxiety; and the greatest prevalence of “recurrent urinary
roblem.”
HYPOTHESES GENERATED
We believe that these facts generate 5 hypotheses.
Hypothesis 1: NBSs and IC/BPS initiate different pro-
cesses that lead to different syndromes. The simplest such
sequences would be:
a) NBS1¡p¡IC/BPS,
where p is the process initiated by NBS1 that leads to
IC/BPS; and
b) IC/BPS¡p=¡NBS1,
where p= is the process initiated by IC/BPS that leads
to NBS1.
This reasoning is simple when the link between 2
syndromes is pondered. However, the logic becomes com-
plicated when considering that multiple NBSs precede IC/
BPS, and some appear to follow it. In the former situation,
each NBS might initiate its own process (pn) that leads to
IC/BPS:
c) NBS1¡p1¡IC/BPS,
NBS2¡p2¡IC/BPS . . . .
Table 2. Prevalence and odds ratios for IC/BPS stratified
by number of coexisting nonbladder syndromes in patients
with prevalent IC/BPS and controls
NBSs*
Patients
(n  205)
Controls
(n  117)
Odds Ratio
(95% CI)
0 60 (29.4) 75 (64.1) Reference
1 46 (22.4) 28 (23.9) 2.1 (1.2-3.7)
2 26 (12.7) 9 (7.7) 3.6 (1.6-8.3)
3 30 (14.6) 1 (0.9) 37.5 (5.0-283.0)
4 18 (8.8) 4 (3.4) 5.6 (1.8-17.5)
5 13 (6.3) 0 (0.0) 33.7 (2.0-578.3)
6 12 (5.9) 0 (0.0) 31.2 (1.8-537.7)
Abbreviations as in Table 1.
Data presented as number of patients, with percentages in
parentheses, unless otherwise noted.
Data calculated from Nickel et al.6
* Eight coexisting NBSs: chronic fatigue syndrome, fibromyalgia,
irritable bowel syndrome, migraine headache, vulvodynia, tension
headache, temporomandibular disorder, and low back pain.NBSn¡pn¡IC/BPS. e
UROLOGY 78 (4), 2011For the latter, the question is whether IC/BPS initiates a
ariety of different processes, each of which leads to a separate
BS:
) IC/BPS¡p1=¡NBS1,
IC/BPS¡p2=¡NBS2, . . . .
IC/BPS¡pn=¡NBSn.
Factoring in the likelihood that such processes also
ink many of the NBSs and might diverge from some
yndromes and converge on others results in an over-
helming number of possible combinations and permu-
ations.
Hypothesis 2: NBSs and IC/BPS initiate a common
rocess that leads to additional syndromes. This hypoth-
sis can be shown as
) any NBS¡p¡IC/BPS,
where p is the common process initiated by each NBS
hat leads to IC/BPS,
and
) IC/BPS¡p¡any NBS,
where p is the same process, now initiated by IC/BPS,
hat leads to any of the NBSs. In this hypothesis, p would
e the common pathogenesis of all but the first syndrome
nd could lead to any other syndrome.
Hypothesis 3: a shared pathophysiology leads to the
BSs and IC/BPS. The simplest, most parsimonious,
ypothesis is that the NBSs and IC/BPS all emerge from
he same pathogenesis, p. Thus, p would precede the first
BS:
)
This pre-existence could mean an origin of “p” in
genetics or in epigenetic or preceding life events.
Small surveys have suggested a genetic predisposition
to IC/BPS,22 and the Swedish twin study estimated
hat genetics accounted for 30% of the variation in the
usceptibility to IC/BPS.23 Additionally, the roles of
aternal stress in fetal development24 and of early life
trauma25,26 on the emergence of IC/BPS have recently
een queried.
Hypothesis 4: a pathophysiology common to the NBSs
nd IC/BPS is found in significantly more patients with
any NBSs than in with fewer.
Hypothesis 5: a pathophysiology unique to IC/BPS is
ound in significantly more patients with only IC/BPS
han in with many NBSs.
At first glance, that IC/BPS risk increases with the
umber of NBSs is not interesting, because it could be
xplained as the accumulation of risk factors. However, a
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ogeneity of IC/BPS.
Numerous students of IC/BPS believe the syndrome to
be heterogenous,7,27,28 which might mean that it has 1
pathogenesis. To simplify this discussion, one could as-
sume that IC/BPS has 2 causes. One is a pathogenesis
that causes IC/BPS but none of the NBSs. The second
causes IC/BPS and, additionally, each of the NBSs. Ac-
counting for age and other factors, one could intuitively
conclude that more patients with IC/BPS and many
NBSs would have this shared pathogenesis than patients
who have IC/BPS with no or few NBSs. This conclusion
also can be shown algebraically.21 It is intriguing that the
classic FSSs of FM, CFS, and IBS were over represented
in IC/BPS patients with many NBSs ie, in the subgroup
in which a shared pathogenesis could be hypothesized to
be most prevalent21.
Additional studies should examine the associations of
NBSs with IC/BPS phenotypes. For example, do patients
with Hunner’s lesions and inflammation differ in the
pattern of associated NBSs compared with patients with
normal-appearing bladders and no inflammation?
Candidate Processes
Each process (p) denoted in the preceding section is
meant to be a series of events that leads to a syndrome.
These events could be structural, physiologic, environ-
mental, behavioral, or another type, perhaps occurring in
patients with a genetic predisposition. Several patho-
physiologies have been shown to accompany these syn-
dromes and thus are candidates for such a process.
Central Sensitization in Lower Spinal Cord. Although
commonly espoused,6,9 central sensitization (CS) at the
ower spinal level might not be an important link between
C/BPS and most of its associated NBSs. The clinical data
an be interpreted to suggest that CS does not commonly
ead to IC/PBS. If it did, the pathophysiology would be that
n NBS that includes pelvic pain initiates CS in the lower
pinal cord such that the bladder also is perceived as a site
f pain. However, this forces the hypothesis that the same
rocess would lead to other pelvic NBSs (ie, that IC/BPS
atients with, for instance, CPP would be more likely to
ave IBS and vulvodynia than IC/BPS patients who did not
ave CPP). However, in the patients with incident IC/BPS,
arren et al5 showed no associations among antecedent
PP, IBS, and vulvodynia.
Nevertheless, 1 NBS after IC/BPS might be explained
y CS at the lower spinal level. Warren et al29 reported
that after the onset of IC/BPS, 23% of patients noted
new symptoms of vulvodynia as a part of their IC/BPS.
This would be consistent with sequence b) above in
which IC/BPS initiated CS in the lower spinal cord,
which resulted in the perception of vulvar pain.
Systemic Pathophysiologies. However, the most com-
pelling reason that CS at the lower spinal cord could not
be responsible for all the NBSs associated with IC/BPS is t
730that most such NBSs have manifestations well beyond
the pelvis. For instance, 1 study revealed that 90% of
patients with IC/BPS had 1 such NBS.5 This observa-
ion could be exceedingly important, because it implies
hat a process outside the pelvis must be responsible for
hese associations. Several candidates for such a process
ave been identified and include abnormalities in su-
raspinal sensory processing, in autonomic function, and
n the hypothalamus-pituitary-adrenal axis.30
However, we assume that no single sequence listed in
the preceding paragraphs will explain all the associations
among the NBSs and IC/BPS, perhaps not even in a
given patient. Nature is complicated, and a combination
of sequences might be responsible. Furthermore, one
could postulate different mediators and modifiers of a
given pathogenesis or various triggers to account for the
onset of different syndromes at different times.
TESTING THE HYPOTHESES
All the facts that generated these hypotheses were re-
vealed in cross-sectional studies of patients with IC/BPS.
In searches for pathogenesis, such a design is often frus-
trating, because the usual residual question is “which
came first?” The temporal relationship of a pathophysi-
ology and a syndrome can be particularly vexing because
of the difficulty in determining whether the revealed
pathophysiology is a cause or an effect of the syndrome.18
In the wider field of human chronic pain research, evidence
has shown that 1 of the noted candidate pathophysiologies,
abnormal sensory processing, can play either role. In pa-
tients undergoing thoracic surgery, pre-existing abnormal
sensory processing was associated with chronic postopera-
tive pain.31 In contrast, in patients with hip osteoarthritis,
yperalgesia at other sites normalized after hip replace-
ent.32
These latter investigations were prospective studies
and suggest that such a design will be necessary to iden-
tify the temporal relationship of a pathophysiology and
IC/BPS. This is because none of the candidate patho-
physiologies are assessed in routine clinical practice or
have markers that can be appraised retrospectively to
discern their times of onset. Thus, additional research of
patients with prevalent IC/BPS should be viewed as
preparatory to prospective investigations of individuals
who have not yet developed IC/BPS.
Cross-Sectional Studies
Cross-sectional studies of prevalent IC/BPS would be
useful for pathogenesis research if they accomplished 2
tasks in each patient and control: (a) estimating the past
sequence of NBSs and, in cases, IC/PBS and (b) assessing
present pathophysiologies. Regarding the former, accu-
racy of syndrome onset could be maximized by the use of
personally important dates as chronologic anchors, iter-
ative queries, and medical records.5 The participants
ould then be distributed into subgroups according to
ypes, numbers, and sequences of syndromes.
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11
1However, the most critical objective of cross-sectional
studies should be to identify the structural, physiologic,
environmental, behavioral, genomic, or other processes
that distinguish patients with IC/BPS from controls. In-
cluded among those that should be sought are the patho-
physiologies listed in previous paragraphs. Cross-sec-
tional studies should screen for additional candidate
pathophysiologies. The processes more common in pa-
tients with IC/BPS would generate the hypothesis that
1 preceded IC/BPS and thus would be a candidate for
its pathogenesis. Of particular interest would be such
studies of patients with recent onset IC/PBS.
Prospective Studies
However, to confirm which processes precede IC/BPS
and thus might cause it, we believe that a prospective
investigation will ultimately be required. The timing of
such a study would depend on the confidence of the
investigators and sponsors that the cross-sectional studies
had identified the important candidate pathophysiolo-
gies. A prospective investigation should have these fea-
tures: restriction to, or powered for, women; the absence
of baseline IC/BPS; periodic assessment of candidate
pathophysiologies, NBSs, and IC/BPS; and comparisons
of those who develop IC/BPS with those who do not.
The selection of the sample will dictate the duration,
expense, and objectives of the study. The shortest and
least expensive would be of women at high risk of IC/BPS
(eg, those with multiple NBSs). The longest and most
expensive would be of women with neither IC/BPS nor
any of the NBSs. Such a study would enroll young
women, possibly girls, and might be able to test all the
hypotheses, maximizing the opportunities to reveal not
only the pathogenesis of IC/BPS, but also the pathogen-
esis(es) of the NBSs. A study that enrolled women with-
out IC/BPS, regardless of the presence of NBSs, would
have possibilities intermediate between these 2 extremes.
CONCLUSIONS
NBSs are associated with IC/PBS and with each other
and might provide important clues to the pathogenesis of
IC/BPS. Additional cross-sectional studies will be useful
to generate hypotheses about the pathogenesis of IC/
BPS; however, prospective studies will likely be necessary
to test these hypotheses.
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